R
28.96
2.48 (9.37%)
| 前收盘价格 | 26.48 |
| 收盘价格 | 26.56 |
| 成交量 | 434,815 |
| 平均成交量 (3个月) | 771,922 |
| 市值 | 1,335,441,280 |
| 市盈率 (P/E TTM) | 24.13 |
| 股市价格/股市净资产 (P/B) | 4.99 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 稀释每股收益 (EPS TTM) | -3.82 |
| 总债务/股东权益 (D/E MRQ) | 2.74% |
| 流动比率 (MRQ) | 31.01 |
| 营业现金流 (OCF TTM) | -67.45 M |
| 杠杆自由现金流 (LFCF TTM) | -47.00 M |
| 资产报酬率 (ROA TTM) | -22.89% |
| 股东权益报酬率 (ROE TTM) | -33.14% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Rapport Therapeutics, Inc. | 看涨 | - |
AIStockmoo 评分
0.3
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.25 |
|
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 6.28% |
| 机构持股比例 | 105.23% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 44.00 (Truist Securities, 51.93%) | 购买 |
| 中 | 39.00 (34.67%) | |
| 低 | 34.00 (HC Wainwright & Co., 17.40%) | 购买 |
| 平均值 | 39.00 (34.67%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 28.83 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Truist Securities | 16 Sep 2025 | 44.00 (51.93%) | 购买 | 26.19 |
| HC Wainwright & Co. | 08 Sep 2025 | 34.00 (17.40%) | 购买 | 31.47 |
| 06 Aug 2025 | 31.00 (7.04%) | 购买 | 14.61 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合